Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
tma intervention rate
tíðni tma inngripa
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tma event-free
Ástand án tma
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
complete tma response
alger tma svörun
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
thrombotic microangiopathy (tma)
blóðstorku-smáæðakvilli (tma)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tma event-free status
Ástand án tma tilvika
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
complete tma response, n (%)
alger tma svörun, n (%)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tma event-free status, n (%)
tma tilvikalaust ástand, n (%)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
duration of current severe clinical tma manifestation
tímalengd yfirstandandi alvarlegra klínískra einkenna tma
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
complete tma response was maintained by all responders.
allir þeir sem svöruðu náðu algerri tma svörun.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tma event-free status, n (%) 95% ci
tma tilvikalaust ástand, n (%)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
patients developing tma should permanently discontinue treatment with pazopanib.
sjúklingar sem þróa með sér segasmáæðakvilla skulu hætta notkun pazópaníbs til frambúðar.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
reversal of effects of tma has been observed after treatment was discontinued.
Áhrif af völdum segasmáæðakvilla hafa gengið til baka eftir að meðferð var hætt.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
daily tma intervention rate, median (range) before eculizumab
tíðni daglegra tma inngripa, miðgildi (bil)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sunitinib therapy should be discontinued in patients who develop tma and prompt treatment is required.
hætta skal sunitinib meðferð hjá sjúklingum sem fá blóðstorku-smáæðakvilla og veita þeim skjóta meðferð.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
damage to the smallest blood vessels known as thrombotic microangiopathy (tma).
skemmdir á minnstu æðunum sem kallast blóðstorku-smáæðakvilli (tma).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
daily tma intervention rate, median (range) before eculizumab treatment, median
tíðni daglegra tma inngripa, miðgildi (bil) fyrir eculizumab meðferð, miðgildi
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
time from current clinical tma manifestation until screening in months, median (min, max)
tími frá yfirstandandi klínískum tma einkennum að skimun í mánuðum, miðgildi (lægst, hæst)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
in paediatric patients with longer duration of current severe clinical tma manifestation prior to eculizumab, there was tma control with eculizumab treatment.
hjá börnum með yfirstandandi einkenni alvarlegs tma sem staðið höfðu yfir í lengri tíma fyrir meðferð með eculizumabi, náðist stjórn á tma með meðferð með eculizumabi.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ahus study c10-004 enrolled 41 patients who displayed signs of thrombotic microangiopathy (tma).
Í ahus rannsókn c10-004 var tekinn inn 41 sjúklingur sem hafði einkenni segaöræðakvilla (tma).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
aflibercept treatment should be discontinued in patients who develop nephrotic syndrome or tma (see section 4.2).
hætta skal aflibercept meðferð hjá sjúklingum sem fá nýrungaheilkenni eða blóðstorku-smáæðakvilla (sjá kafla 4.2).
Last Update: 2017-04-26
Usage Frequency: 1
Quality: